Interferon-γ 1b: impact of new indications (idiopathic pulmonary fibrosis)
AN Aggarwal, D Behera - Expert Opinion on Pharmacotherapy, 2000 - Taylor & Francis
Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive disease with inadequate
response to conventional treatment with corticosteroids and/or immunosuppressive agents …
response to conventional treatment with corticosteroids and/or immunosuppressive agents …
Interferon gamma-1b in the treatment of idiopathic pulmonary fibrosis
MA Pacanowski, GW Amsden - Annals of Pharmacotherapy, 2005 - journals.sagepub.com
Objective: To examine the clinical aspects of idiopathic pulmonary fibrosis (IPF) and the
efficacy and safety of interferon gamma-1b (IFNγ− 1b) in its treatment. Data Sources …
efficacy and safety of interferon gamma-1b (IFNγ− 1b) in its treatment. Data Sources …
Long-term survival in idiopathic pulmonary fibrosis patients treated with interferon gamma-1b.(Interstitial lung disease: outcomes: 2: 00pm-3: 30pm)
R Ziesche, WZ Bradford, M Crager, LH Block - Chest, 2002 - go.gale.com
PURPOSE: Idiopathic Pulmonary Fibrosis (IPF) is characterized by progressive respiratory
insufficiency and a median survival of only 2-5 years. There is no therapy for IPF with …
insufficiency and a median survival of only 2-5 years. There is no therapy for IPF with …
Does interferon‐γ improve pulmonary function in idiopathic pulmonary fibrosis?
A Prasse, KM Müller, C Kurz, H Hamm… - European Respiratory …, 2003 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) is a disease with progressive and devastating
deterioration of lung function and a fatal prognosis, despite aggressive therapeutic attempts …
deterioration of lung function and a fatal prognosis, despite aggressive therapeutic attempts …
Interferon-γ1b for the treatment of idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) represents a particularly aggressive disease, the
aetiology of which still remains unknown. The natural history of the disease often leads to …
aetiology of which still remains unknown. The natural history of the disease often leads to …
Interferon-γ1b therapy in idiopathic pulmonary fibrosis: a metaanalysis
EK Bajwa, NT Ayas, M Schulzer, E Mak, JH Ryu… - Chest, 2005 - Elsevier
Context Despite the investigation of multiple therapeutic options, idiopathic pulmonary
fibrosis (IPF) remains a devastating, progressively fatal disease. Much interest has focused …
fibrosis (IPF) remains a devastating, progressively fatal disease. Much interest has focused …
Treatment of idiopathic pulmonary fibrosis: is there anything new?
MM Abdelaziz, YS Samman, SO Wali… - …, 2005 - Wiley Online Library
Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic fibrosing interstitial
pneumonia of unknown aetiology and is associated with the histological picture of usual …
pneumonia of unknown aetiology and is associated with the histological picture of usual …
[HTML][HTML] Gamma Interferon and prednisone decreasing-dose therapy in patients with Idiopathic Pulmonary Fibrosis
I Cayón, L González, I García, C Rosas… - Biotecnologia …, 2010 - scielo.sld.cu
Idiopathic pulmonary fibrosis (IPF) is a fatal disease to which no treatment has demonstrated
to be a modifier of the disease pattern. The aim of this study was to obtain evidences of the …
to be a modifier of the disease pattern. The aim of this study was to obtain evidences of the …
[HTML][HTML] A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
G Raghu, KK Brown, WZ Bradford… - … England Journal of …, 2004 - Mass Medical Soc
Background Idiopathic pulmonary fibrosis is a progressive, fatal disease with no known
efficacious therapy. Methods In a double-blind, multinational trial, we randomly assigned …
efficacious therapy. Methods In a double-blind, multinational trial, we randomly assigned …
Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis
KM Antoniou, AG Nicholson, M Dimadi… - European …, 2006 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF)/usual interstitial pneumonia is a deadly disease with no
effective treatment. The purpose of this randomised prospective multicentric study was to …
effective treatment. The purpose of this randomised prospective multicentric study was to …